Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients

NCT03408964 · clinicaltrials.gov ↗
RECRUITING
Status
600
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Oncology Institute of Southern Switzerland

Collaborators